Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07583810
What this trial is testing

Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma

Who this might be right for
Conjunctival Mucosa-Associated Lymphoid Tissue LymphomaGastric Mucosa-Associated Lymphoid Tissue LymphomaMarginal Zone Lymphoma+4 more
City of Hope Medical Center 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04542824
What this trial is testing

Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaPrimary Mediastinal Large B Cell Lymphoma+3 more
Genmab 78
Large-scale testing (Phase 3)Study completedNCT00327678
What this trial is testing

Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults

Who this might be right for
Leukemia, Lymphocytic
Assistance Publique - Hôpitaux de Paris 1,080
Testing effectiveness (Phase 2)Ended earlyNCT00077961
What this trial is testing

Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL

Who this might be right for
Non-Hodgkin's Lymphoma
Genzyme, a Sanofi Company 49
Testing effectiveness (Phase 2)Study completedNCT03129828
What this trial is testing

Ibrutinib, Bortezomib and Rituximab-CHOP for the Treatment of Elderly Patients With CD20+ DLBCL, IPI ≥ 2

Who this might be right for
Diffuse Large B Cell Lymphoma
Prof. Dr. Clemens Schmitt 38
Testing effectiveness (Phase 2)Looking for participantsNCT06688331
What this trial is testing

Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody

Who this might be right for
Presymptomatic Diabetes Type 1 (Stage 1)Diabetes Mellitus, Type IDiabetes Mellitus, Type 1
PolTREG S.A. 150
Early research (Phase 1)WithdrawnNCT00521261
What this trial is testing

Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT02532257
What this trial is testing

Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone Lymphoma

Who this might be right for
Ann Arbor Stage II Follicular LymphomaAnn Arbor Stage II Marginal Zone LymphomaAnn Arbor Stage III Follicular Lymphoma+7 more
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)Looking for participantsNCT02393157
What this trial is testing

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

Who this might be right for
Non-Hodgkin LymphomaBurkitt LymphomaDiffuse Large B-Cell Lymphoma+3 more
New York Medical College 25
Large-scale testing (Phase 3)Study completedNCT01134432
What this trial is testing

Prednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic Anemia

Who this might be right for
Anemia, Hemolytic, Autoimmune
Copenhagen University Hospital at Herlev 65
Early research (Phase 1)Ended earlyNCT00176475
What this trial is testing

Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
University of Medicine and Dentistry of New Jersey 2
Early research (Phase 1)Study completedNCT01842386
What this trial is testing

Rituximab for Anti-cytokine Autoantibody-Associated Diseases

Who this might be right for
Pulmonary Alveolar Proteinosis (PAP)Severe Mucocutaneous Candidiasis
National Institute of Allergy and Infectious Diseases (NIAID) 7
Post-approval studies (Phase 4)UnknownNCT05718856
What this trial is testing

TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 166
Testing effectiveness (Phase 2)Active Not RecruitingNCT03888105
What this trial is testing

Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies

Who this might be right for
B-cell Non-Hodgkin Lymphoma (B-NHL)
Regeneron Pharmaceuticals 515
Early research (Phase 1)Looking for participantsNCT05668403
What this trial is testing

A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Shanghai Jiaolian Drug Research and Development Co., Ltd 52
Testing effectiveness (Phase 2)Study completedNCT04893096
What this trial is testing

MOR202 for Refractory MN

Who this might be right for
Membranous Nephropathy
Mario Negri Institute for Pharmacological Research 10
Large-scale testing (Phase 3)Study completedNCT02229942
What this trial is testing

B-lymphocyte Depletion Using Rituximab in Chronic Fatigue Syndrome/ Myalgic Encephalopathy (CFS/ME). A Randomized Phase-III Study.

Who this might be right for
Chronic Fatigue Syndrome/ Myalgic Encephalitis (CFS/ME)
Haukeland University Hospital 151
Early research (Phase 1)Looking for participantsNCT07304154
What this trial is testing

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

Who this might be right for
Chronic Inflammatory Demyelinating PolyneuropathyMyasthenia GravisMultiple Sclerosis
Kite, A Gilead Company 52
Testing effectiveness (Phase 2)Ended earlyNCT01147393
What this trial is testing

Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Weill Medical College of Cornell University 4
Early research (Phase 1)WithdrawnNCT02556346
What this trial is testing

Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic B-cell Lymphocytic LeukemiaSmall Lymphocytic Leukemia
Molecular Templates, Inc.
Next Page